QIAGEN NV ORD EUR0.01 (POST REV SPLIT)QIAGEN NV ORD EUR0.01 (POST REV SPLIT)QIAGEN NV ORD EUR0.01 (POST REV SPLIT)

QIAGEN NV ORD EUR0.01 (POST REV SPLIT)

No trades
See on Supercharts

Price target

50.260.000.00%
The 18 analysts offering 1 year price forecasts for 0RLT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 21 analysts giving stock ratings to 0RLT in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0RLT EPS for the last quarter is 0.53 EUR despite the estimation of 0.50 EUR. In the next quarter EPS is expected to reach 0.60 EUR. Track more of QIAGEN NV ORD EUR0.01 (POST REV SPLIT) financials and stay on top of what is up with the company.
In the next quarter QIAGEN NV ORD EUR0.01 (POST REV SPLIT) revenue is expected to reach ‪503.29 M‬ EUR. Check out QIAGEN NV ORD EUR0.01 (POST REV SPLIT) revenue and earnings and make informed decisions.
According to analysts, 0RLT price target is 50.26 EUR with a max estimate of 59.41 EUR and a min estimate of 44.56 EUR. Check if this forecast comes true in a year, meanwhile watch QIAGEN NV ORD EUR0.01 (POST REV SPLIT) stock price chart and keep track of the current situation with 0RLT news and stock market news.
We've gathered opinions of 21 analysts rating 0RLT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.